INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $48,080 | -83.4% | 107,687 | -42.1% | 0.00% | -100.0% |
| Q4 2022 | $290,115 | -40.7% | 185,971 | -34.4% | 0.00% | -50.0% |
| Q3 2022 | $489,000 | +129.6% | 283,529 | +130.7% | 0.00% | +100.0% |
| Q2 2022 | $213,000 | +432.5% | 122,902 | +1017.3% | 0.00% | – |
| Q1 2022 | $40,000 | -78.6% | 11,000 | -70.7% | 0.00% | -100.0% |
| Q4 2021 | $187,000 | +14.7% | 37,500 | +64.5% | 0.00% | 0.0% |
| Q3 2021 | $163,000 | -68.2% | 22,800 | -58.8% | 0.00% | -60.0% |
| Q2 2021 | $513,000 | -45.5% | 55,351 | -48.0% | 0.01% | -61.5% |
| Q4 2020 | $942,000 | +698.3% | 106,443 | +949.3% | 0.01% | +550.0% |
| Q3 2020 | $118,000 | – | 10,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |